Predictions
Tilray Inc
Start price
Target price
Perf. (%)
€6.34
14.11.20
14.11.20
-
14.11.21
14.11.21
-1.09%
27.11.20
27.11.20
Significant cyclical dependencies
Higher risks for its business
Probably not worthwhile Investment
Gilead Sciences Inc
Start price
Target price
Perf. (%)
€51.30
14.11.20
14.11.20
-
14.11.21
14.11.21
-1.75%
23.11.20
23.11.20
Known brand
Fair valuation
Leading role in innovation
Future proof or reliable business model
Enzon Pharmaceuticals
Start price
Target price
Perf. (%)
€0.10
14.11.20
14.11.20
-
14.11.21
14.11.21
120.00%
14.01.21
14.01.21
Risky Investment
Nicheplayer
Higher risks for its business
Verisk Analytics A
Start price
Target price
Perf. (%)
€174.02
13.11.20
13.11.20
-
13.11.21
13.11.21
-9.85%
13.02.21
13.02.21
EBIT growth >5% per year expected
Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
Very low/no dividend yield expected
International Business Machines Corp
Start price
Target price
Perf. (%)
€98.48
13.11.20
13.11.20
€118.00
13.11.21
13.11.21
5.71%
14.11.21
14.11.21
Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Undervalued
International Business Machines Corp
Start price
Target price
Perf. (%)
€98.00
13.11.20
13.11.20
-
13.11.21
13.11.21
26.48%
10.06.21
10.06.21
Gilead Sciences Inc
Start price
Target price
Perf. (%)
€50.60
13.11.20
13.11.20
€52.00
1.38%
14.11.20
14.11.20
Known brand
Fair valuation
Leading role in innovation
Future proof or reliable business model
Apple Inc.
Start price
Target price
Perf. (%)
€101.48
13.11.20
13.11.20
€110.00
3.84%
16.12.20
16.12.20
positive Cash Flow expected
Standard Investments for future growth
Valuable balance sheet
Normal challenges to pay loans and raise capital
T-Mobile US Inc.
Start price
Target price
Perf. (%)
€106.88
12.11.20
12.11.20
€110.00
4.79%
14.11.20
14.11.20
Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
Valuable balance sheet
ROE higher than 10% per year
Truist Financial Corp.
Start price
Target price
Perf. (%)
€41.60
11.11.20
11.11.20
-
11.11.21
11.11.21
5.29%
14.01.21
14.01.21
Very high dividend yield expected
Probably not worthwhile Investment
Business model of the past or high risk
Borgwarner Inc.
Start price
Target price
Perf. (%)
€33.00
10.11.20
10.11.20
-
10.11.21
10.11.21
10.91%
11.09.21
11.09.21
Below average Marketposition
Business model of the past or high risk
Data I/O Corp.
Start price
Target price
Perf. (%)
€2.86
10.11.20
10.11.20
€4.00
10.11.21
10.11.21
5.59%
16.11.20
16.11.20
Could be worthwhile Investment >10% per year
Innodata Inc.
Start price
Target price
Perf. (%)
€2.34
10.11.20
10.11.20
€4.00
10.11.21
10.11.21
41.03%
16.11.20
16.11.20
Could be worthwhile Investment >10% per year
Marin Software
Start price
Target price
Perf. (%)
€1.66
10.11.20
10.11.20
€3.00
10.11.21
10.11.21
-9.04%
16.11.20
16.11.20
Could be worthwhile Investment >10% per year
Mandiant Inc.
Start price
Target price
Perf. (%)
€12.90
10.11.20
10.11.20
-
10.11.21
10.11.21
44.21%
19.01.21
19.01.21
Future proof or reliable business model
Innovative
Growths slower than the competition
Beyond Meat Inc
Start price
Target price
Perf. (%)
€100.00
10.11.20
10.11.20
-
04.11.21
04.11.21
15.34%
16.12.20
16.12.20
Revenue growth >5% per year expected
Gilead Sciences Inc
Start price
Target price
Perf. (%)
€50.00
09.11.20
09.11.20
€55.00
2.66%
10.11.20
10.11.20
Known brand
Fair valuation
Leading role in innovation
Future proof or reliable business model
Pfizer Inc.
Start price
Target price
Perf. (%)
€33.30
09.11.20
09.11.20
€37.95
-11.94%
17.12.20
17.12.20
Capable Management
Good culture
Innovative
Differentiated customer and product portfolio
Oncternal Therapeutics Inc.
Start price
Target price
Perf. (%)
€5.15
08.11.20
08.11.20
€5.00
08.11.21
08.11.21
-29.28%
09.11.21
09.11.21
Could be worthwhile Investment >10% per year
Qorvo Inc.
Start price
Target price
Perf. (%)
€126.00
07.11.20
07.11.20
-
07.11.21
07.11.21
18.25%
24.03.21
24.03.21
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Some uniques
Growths slower than the competition